Cargando…

Sodium valproate-induced enuresis in a pediatric bipolar patient

Sodium valproate (SV) is effective and well tolerated for the treatment of epilepsy and mood disorders. There are several cases of SV-induced enuresis noted in epileptic patients. No alternative medication has been suggested to manage this problem. We present the first case of a pediatric bipolar pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Wentao, Lin, Xiaoling, Lu, Dali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817031/
https://www.ncbi.nlm.nih.gov/pubmed/24204152
http://dx.doi.org/10.2147/NDT.S53388
_version_ 1782478005805776896
author Cheng, Wentao
Lin, Xiaoling
Lu, Dali
author_facet Cheng, Wentao
Lin, Xiaoling
Lu, Dali
author_sort Cheng, Wentao
collection PubMed
description Sodium valproate (SV) is effective and well tolerated for the treatment of epilepsy and mood disorders. There are several cases of SV-induced enuresis noted in epileptic patients. No alternative medication has been suggested to manage this problem. We present the first case of a pediatric bipolar patient who developed diurnal and nocturnal enuresis during SV therapy. Clinicians should be aware of this side effect, as it has not been reported in nonepileptic patients, and it may be detrimental to treatment adherence.
format Online
Article
Text
id pubmed-3817031
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-38170312013-11-07 Sodium valproate-induced enuresis in a pediatric bipolar patient Cheng, Wentao Lin, Xiaoling Lu, Dali Neuropsychiatr Dis Treat Case Report Sodium valproate (SV) is effective and well tolerated for the treatment of epilepsy and mood disorders. There are several cases of SV-induced enuresis noted in epileptic patients. No alternative medication has been suggested to manage this problem. We present the first case of a pediatric bipolar patient who developed diurnal and nocturnal enuresis during SV therapy. Clinicians should be aware of this side effect, as it has not been reported in nonepileptic patients, and it may be detrimental to treatment adherence. Dove Medical Press 2013 2013-10-31 /pmc/articles/PMC3817031/ /pubmed/24204152 http://dx.doi.org/10.2147/NDT.S53388 Text en © 2013 Cheng et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed.
spellingShingle Case Report
Cheng, Wentao
Lin, Xiaoling
Lu, Dali
Sodium valproate-induced enuresis in a pediatric bipolar patient
title Sodium valproate-induced enuresis in a pediatric bipolar patient
title_full Sodium valproate-induced enuresis in a pediatric bipolar patient
title_fullStr Sodium valproate-induced enuresis in a pediatric bipolar patient
title_full_unstemmed Sodium valproate-induced enuresis in a pediatric bipolar patient
title_short Sodium valproate-induced enuresis in a pediatric bipolar patient
title_sort sodium valproate-induced enuresis in a pediatric bipolar patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817031/
https://www.ncbi.nlm.nih.gov/pubmed/24204152
http://dx.doi.org/10.2147/NDT.S53388
work_keys_str_mv AT chengwentao sodiumvalproateinducedenuresisinapediatricbipolarpatient
AT linxiaoling sodiumvalproateinducedenuresisinapediatricbipolarpatient
AT ludali sodiumvalproateinducedenuresisinapediatricbipolarpatient